Literature DB >> 16865352

[Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs].

J Schmitt1, M Meurer.   

Abstract

Most patients with mild to moderate psoriasis require--often longterm--topical treatments: this frequently results in non-compliance especially when large body areas or the face are treated. Monotherapy with anthralin has been abandoned to a great extent while new formulations of topical corticosteroids, vitamin D and vitamin D derivatives have greatly extended the spectrum of topical antipsoriatic treatment modalities. In most instances, combinations of preparations with different pharmacologic modes of action are superior when compared with the respective monotherapy. This also holds true for combinations with a UVB or UVA light therapy. Preparations containing both a corticosteroid and vitamin D derivative are well suited for combining topical treatment with modern systemic antipsoriatic drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865352     DOI: 10.1007/s00105-006-1193-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  24 in total

Review 1.  [Topical treatment of psoriasis: a systematic update].

Authors:  R Aschoff; G Wozel; M Meurer
Journal:  Hautarzt       Date:  2003-02-13       Impact factor: 0.751

2.  Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.

Authors:  Christie L Carroll; Steven R Feldman; Fabian T Camacho; Janeen C Manuel; Rajesh Balkrishnan
Journal:  J Am Acad Dermatol       Date:  2004-08       Impact factor: 11.527

Review 3.  Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review.

Authors:  J Koo
Journal:  J Am Acad Dermatol       Date:  1997-09       Impact factor: 11.527

4.  Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study.

Authors:  T Ruzicka; B Lorenz
Journal:  Br J Dermatol       Date:  1998-02       Impact factor: 9.302

Review 5.  Combination topical therapy for the treatment of psoriasis.

Authors:  James Q Del Rosso Do
Journal:  J Drugs Dermatol       Date:  2006-03       Impact factor: 2.114

6.  Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.

Authors:  J N Barker; R E Ashton; R Marks; R I Harris; J Berth-Jones
Journal:  Br J Dermatol       Date:  1999-08       Impact factor: 9.302

7.  The UVB-induced synthesis of vitamin D3 and 1alpha,25-dihydroxyvitamin D3 (calcitriol) in organotypic cultures of keratinocytes: effectiveness of the narrowband Philips TL-01 lamp (311 nm).

Authors:  Bodo Lehmann; Peter Knuschke; Michael Meurer
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-18       Impact factor: 4.292

8.  Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.

Authors:  L Guenther; P C M Van de Kerkhof; E Snellman; K Kragballe; A C Chu; E Tegner; A Garcia-Diez; J Springborg
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

9.  Objective assessment of compliance with psoriasis treatment.

Authors:  Sameh Said Zaghloul; Mark Jeremy David Goodfield
Journal:  Arch Dermatol       Date:  2004-04

10.  Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.

Authors:  Morad Lahfa; Ulrich Mrowietz; Miriam Koenig; Jan C Simon
Journal:  Eur J Dermatol       Date:  2003 May-Jun       Impact factor: 3.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.